High STAT4 expression correlates with poor prognosis in acute myeloid leukemia and facilitates disease progression by upregulating VEGFA expression
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Signal transducer and activator of transcription 4 (STAT4) is upregulated in acute myeloid leukemia (AML). STAT4 promotes AML progression by increasing viability and angiogenesis, while high STAT4 expression correlates with poor prognosis.
Area Of Science
- Hematology
- Molecular Biology
- Oncology
Background
- Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
- The molecular mechanisms underlying AML pathogenesis require further elucidation.
- Signal transducer and activator of transcription 4 (STAT4) role in AML is not fully understood.
Purpose Of The Study
- To investigate the role and mechanism of STAT4 in acute myeloid leukemia (AML).
- To analyze the correlation between STAT4 expression and AML patient prognosis.
- To determine the impact of STAT4 on AML cell viability, apoptosis, and angiogenesis.
Main Methods
- Bioinformatic analysis and quantitative real-time PCR of STAT4 levels in AML samples.
- In vitro studies involving STAT4 silencing and overexpression in AML cells.
- Assessment of cell viability, apoptosis, and angiogenesis.
- Examination of STAT4, vascular endothelial growth factor A (VEGFA), Bcl-2, and Bax protein levels.
Main Results
- STAT4 expression is upregulated in AML.
- STAT4 silencing reduced AML cell viability and angiogenesis, and increased apoptosis.
- STAT4 overexpression had opposite effects on viability, angiogenesis, and apoptosis.
- VEGFA silencing reversed the pro-survival and anti-apoptotic effects of STAT4 overexpression.
- High STAT4 expression is linked to poor prognosis and disease progression in AML patients.
Conclusions
- STAT4 plays a significant role in promoting AML progression.
- STAT4 upregulates VEGFA expression, contributing to increased viability and angiogenesis, and decreased apoptosis in AML.
- STAT4 is a potential therapeutic target for improving AML prognosis.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...